Company Quick10K Filing
Quick10K
Rich Pharmaceuticals
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-K 2018-03-31 Annual: 2018-03-31
10-Q 2017-12-31 Quarter: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-K 2017-03-31 Annual: 2017-03-31
10-Q 2016-12-31 Quarter: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-K 2016-03-31 Annual: 2016-03-31
10-Q 2015-12-31 Quarter: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-K 2015-03-31 Annual: 2015-03-31
10-Q 2014-12-31 Quarter: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-K 2014-03-31 Annual: 2014-03-31
10-Q 2013-12-31 Quarter: 2013-12-31
8-K 2019-06-11 Enter Agreement, Sale of Shares, Officers, Shareholder Vote, Exhibits
8-K 2019-02-12 Enter Agreement, Sale of Shares, Other Events, Exhibits
8-K 2018-04-10 Sale of Shares
8-K 2018-03-15 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-03-02 Sale of Shares
8-K 2018-02-09 Sale of Shares
8-K 2018-02-01 Sale of Shares
8-K 2018-01-18 Sale of Shares
8-K 2018-01-10 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-01-02 Sale of Shares

Rich Pharmaceuticals Financials

-

RCHA Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comparables ($'000 Annual) Ticker Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Ryanair Holdings RYAA -0 13,250,700 8,035,800 0 0 0 0 -34,900
Lingo Media LMDC -0 1,302 743 0 0 0 0 -0
Apollo Education APOL 1,063,295 1,955,243 886,324 2,000,328 0 -19,719 62,995 579,272
China Crawfish CACA -0 2 0 0 0 -4 -4 -3
Mirenco MREO
Granite Real Estate GRP
Weyland Tech WEYL -0 10,602 5,280 29,462 -958 -4,242 -4,099 -5,303
Baynon BNON -0 11 145 0 0 -21 -20 99
Green Planet Bio Engineering GPLB 3,001 0 272 0 0 -38 -38 3,001
G-Mes Holdings GMES -0 1,262 812 652 609 67 141 -31
Immune Therapeutics IMUN 0 24 12,553 0 34 -5,080 -5,079 -21
Therapeutic Solutions TSOI 0 367 1,851 13 10 -1,579 -1,236 481
Blue Sphere BLSP 894 43,956 86,868 7,950 2,700 -14,453 -14,295 8,802
Frontier Digital Media Group FDMG -0 5 31 32 0 -29 -29 -3
Stem Holdings STEMH -0 40,803 5,703 958 364 -8,070 -7,496 -5,454
MWF Global MWF -0 -0 -0 0 0 -34 -34 -1
Clean Coal Technologies CCTC -0 27 16,749 0 0 -5,795 -3,052 894
SpringWorks SWTX
Brighthouse Life Insurance Co of Ny BHNY -0 9,065,749 8,029,864 236,819 0 0 2,514 -190,199
Imine JRVS 5,585 2 590 0 0 -1,527 -1,527 6,083

Balance Sheet ($'000)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-31
Cash42601018120461600300004142546
Accounts Receivable
Inventory
PP&E111111111433222211
Assets42608448151036892463576325321573537
Accounts Payable1812481701839109169119811,1391,155351367350350312352327
Long-Term Debt
Liabilities1731972102138536181,0251,2161,7431,7631,9122,5782,3982,5182,7613,2085,3797,5305,3635,2466,396
Stockholders' Equity-13-29-37-126-166-837-515-1,018-1,127-1,719-1,757-1,909-2,573-2,392-2,512-2,758-3,205-5,326-7,509-5,306-5,211-6,359
Income Statement ($'000)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-31
Revenue00000000000000000011500
Cost of Revenue
Gross Profit
R&D7200007214819391
SG&A
Tax00000000000000000000
Net Income-16-8-124-190-520-671-1,436-1,506-648-309-901-178-267-540-2,256-2,3021,79655-1,242
Cash Flow ($'000)2012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-31
Cash Operating-13-6-165-91-81-352-398-284-411-142-89-112-152-132-58-264-176-118-76-139
Cash Investing-1-2300-1-3-10-503
Cash Financing116413710098340402286421126891161511325831514415455138